Improved process for preparing alphapolymorphic eletriptan hydrobromide

Details for Australian Patent Application No. 2004256994 (hide)

Owner Pfizer Limited

Inventors Kelly, Cornelius Joseph; Furlong, Patrick Joseph; Ogilvie, Ronald James; Ryan, Vincent

Agent Allens Arthur Robinson

Pub. Number AU-A-2004256994

PCT Pub. Number WO2005/007649

Priority 0317229.3 23.07.03 GB

Filing date 12 July 2004

Wipo publication date 27 January 2005

International Classifications

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2005/007649 Priority application(s): WO2005/007649

11 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004257000-Oligodendrocyte precursor cells and methods of obtaining and culturing the same

2004256980-Droplet deposition apparatus